CTVA Form 4: SVP/CLO awarded RSUs and options exercisable through 2035

Rhea-AI Filing Summary

Insider grants to Corteva SVP and Chief Legal Officer Jennifer Amy Johnson — The Form 4 discloses that on 09/15/2025 Ms. Johnson was granted 4,282 restricted stock units (RSUs) and a non-qualified stock option for 12,418 shares with an exercise price of $70.07. The RSUs vest in three equal annual installments beginning on the grant date and the option likewise vests in three equal annual installments; the option expires on 09/15/2035. Following the transactions, Ms. Johnson directly beneficially owns 4,282 common shares and holds options covering 12,418 shares. The Form 4 was signed under power of attorney on 09/17/2025.

Insights

Corporate Governance Expert

TL;DR: Routine executive equity awards align management incentives without indicating unusual governance risk.

The disclosed grants are standard long-term incentive tools: time-based RSUs and a time-vested non-qualified option. Vesting over three years ties retention to tenure and aligns the CLO with shareholder value creation. There is no disclosure here of accelerated vesting, related-party issues, or change-in-control provisions, and ownership is direct. Given the information, this filing appears to be a customary compensation action rather than a governance red flag.

Compensation Analyst

TL;DR: Awards size and structure are typical for an SVP/CLO; option strike equals reported exercise price of $70.07.

The package consists of 4,282 RSUs and a 12,418-share non-qualified option exercisable through 2035, vesting in three equal installments. The effective grant-to-option ratio and multi-year vesting promote retention and potential upside participation if stock price appreciates above $70.07. No cash compensation or total target long-term incentive value is provided, limiting quantitative assessment of mix versus peer practices.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Johnson Jennifer Amy

(Last) (First) (Middle)

C/O CORTEVA, INC.

9330 ZIONSVILLE ROAD

(Street)

INDIANAPOLIS IN 46268

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Corteva, Inc. [ CTVA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Chief Legal Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/15/2025		A		4,282(1)	A	$0	4,282	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right-to-buy)	$70.07	09/15/2025		A		12,418		(2)	09/15/2035	Common Stock	12,418	$0	12,418	D

Explanation of Responses:

1. Represents grant of restricted stock units which vest in three equal annual installments on the first, second, and third anniversaries of the grant date.

2. The option vests in three equal annual installments on the first, second, and third anniversaries of the grant date.

	/s/Abigail Jarrell, by power-of-attorney	09/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did Corteva insider Jennifer Amy Johnson report on Form 4 (CTVA)?

Answer: She reported receiving 4,282 RSUs and a non-qualified stock option for 12,418 shares with an exercise price of $70.07, both granted 09/15/2025.

When do the RSUs and options granted to Jennifer Amy Johnson vest?

Answer: Both the RSUs and the option vest in three equal annual installments on the first, second, and third anniversaries of the 09/15/2025 grant date.

How many shares does Jennifer Amy Johnson beneficially own after the reported transactions?

Answer: The Form 4 reports she directly beneficially owns 4,282 common shares and holds options covering 12,418 additional shares.

What is the expiration date for the option granted to Jennifer Amy Johnson?

Answer: The non-qualified stock option expires on 09/15/2035 per the filing.

Who signed the Form 4 for Jennifer Amy Johnson and when?

Answer: The Form 4 was signed by /s/Abigail Jarrell, by power-of-attorney on 09/17/2025.